Monopar Therapeutics  logo
Monopar Therapeutics MNPR
$ 19.63 3.32%

Quarterly report 2024-Q3
added 11-08-2024

report update icon

Monopar Therapeutics ROA Ratio 2011-2024 | MNPR

Annual ROA Ratio Monopar Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-114.39 -79.5 -44.36 -37.37 -31.64 - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-31.64 -114.39 -61.45

Quarterly ROA Ratio Monopar Therapeutics

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-90.85 -90.64 -64.59 -81.2 -75.08 -70.31 -46.72 -57.64 -51.94 -43.94 -26.7 -36.41 -35.22 -35.28 -24.76 -30.27 -26.06 -24.28 -22.6 -34.77 -38.01 -43.39 -45.25 -182.88 -323.93 -317.72 -159.51 -159.51 -9.71 -3.75 - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
-3.75 -323.93 -75.1